Medical Oncology

Primary Immunodeficiency

Questions discussed in this category

Would you consider the use of ruxolitinib for tumor fevers and leukocytosis?

Patient with what is thought to be paraneoplastic neutrophilia, and cyclical fevers from metastatic disease. Repeated testing for infection has been n...

1 Answer available

Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?

2 Answers available

Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?

5 Answers available

What is your surveillance protocol for patients with common variable immunodeficiency receiving chronic IVIG therapy?

Is there a target IgG level to aim for? What should hematologists be aware of in monitoring these patients?

1 Answer available

What is your approach to working up diarrhea in an immunocompromised patient?

1 Answer available

Do you recommend shingles vaccine to all immunosuppressed patients under the age of 50 y.o.?

1 Answer available

How do you handle hypogammaglobulinemia detected in patients prior to maintenance rituximab infusion?

2 Answers available

Papers discussed in this category

JAMA network open, 2018-11-02

Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia.

Lupus, 2014 Jul 30

Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections.

MMWR. Morbidity and mortality weekly report, 2024 Sep 12

Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.

Medical Oncology

Primary Immunodeficiency

Questions discussed in this category

Papers discussed in this category

Related Topics in Medical Oncology